Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Sponsor
Ludwig Boltzmann Institute for Lung Health
Study ID
NCT06522334
Status
Recruiting
Apply to this trial

Conditions

  • Interstitial Lung Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death. There are no additional interventions regarding this registry.

Key Dates

First listed
Jul 26, 2024
Start date
Feb 28, 2024
Status verified
Mar 2025
Primary completion
Feb 28, 2034
Completion
Feb 28, 2034

Study Design

Enrollment
400 participants (estimated)

Primary Outcome Measure

Mortality [ Time Frame: 10 years ]

Related Studies